Merck Stops Developing COVID Vaccine, Says ‘Natural Infection’ Leads To Better Herd Immunity
By Krizzia Paolyn Reyes – Feb 01, 2021
U.S.-based vaccine company Merck announced on Jan. 25 that they will stop developing vaccines for the 2019 novel coronavirus since natural infections are better than vaccines in producing results leading to herd immunity.
Merck, or MSD outside of the United States and Canada, announced on the 25th of January that they will discontinue any further developments on their SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591, and instead plans to focus its SARS-CoV-2/COVID-19 research strategy and production capabilities on advancing two therapeutic candidates, MK-4482 and MK-7110, as written on their website.
Former Vice President of Pfizer Dr. Michael Yeadon denied the need for vaccines for COVID-19.
“There is absolutely no need for vaccines to extinguish the pandemic. I’ve never heard such nonsense talked about vaccines. You do not vaccinate people who aren’t at risk from a disease. You also don’t set about planning to vaccinate millions of fit and healthy people with a vaccine that hasn’t been extensively tested on human subjects.“ Yeadon said.
Yeadon also explained that it “has less than a 0.03 percent fatality rate and most of those people, I believe 92 percent or above, have other health problems; we’re making a vaccine at warp speed for a virus that doesn’t look like it’s going to need a vaccine.”
He continued by saying that “it is possible, but I don’t believe it is desirable, nor do I believe that it’s safe,” with as much as “15 per cent of the very healthy young volunteers (experiencing) significant side effects.”
Continue reading from PDF below:
